Skip to content
value.today

Alleviant Medical, Inc.

🇺🇸 Houston, Texas, USABiotechnologyFounded 2017
Total raised
$149 M
4 rounds on record
Latest round
$91 M
Dec 2024
First round on record
Dec 2017
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Alleviant Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2024$91 MNo. 4$50 to $250 million

Alleviant Medical, Inc.: Raise no. 4, Dec 2024

Investors in this round

12 investors had bought by the notice of Jan 27, 2025: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$91 M of $91 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam Berman · Executive Officer, Director
  • Brian R Smith · Director
  • Christopher R Kaster · Director
  • Geoff R Pardo · Director
  • Ian R Meredith · Director
  • Jay R Schmelter · Director
  • Kirk R Nielsen · Director
  • Maria R Berkman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total amount sold in Item 13(b) includes equity investment to be paid in the future under investors' purchase commitments.”

Signed by Adam Berman, Ceo. Newest notice filed Jan 27, 2025. Read the notice at the SEC.

equitySEC
Jan 2023$44 MNo. 3$10 to $50 million

Alleviant Medical, Inc.: Raise no. 3, Jan 2023

Investors in this round

35 investors had bought by the notice of Feb 7, 2023: 35 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$44 M of $88 M offered; $44 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam Berman · Executive Officer, Director
  • Brian R Smith · Director
  • Christopher R Kaster · Director
  • Gowda R Ashok · Director
  • Jay R Schmelter · Director
  • Kirk R Nielson · Director
  • Maria Berkman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Adam Berman, Ceo. Newest notice filed Feb 7, 2023. Read the notice at the SEC.

equitySEC
May 2020$13 MNo. 2$10 to $50 million

Alleviant Medical, Inc.: Raise no. 2, May 2020

Investors in this round

18 investors had bought by the notice of Nov 5, 2020: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $20 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam Berman · Executive Officer, Director
  • Ashok Gowda · Director
  • Christopher Kaster · Director
  • Jacob Kriegel · Director
  • Kirk Nielsen · Director
  • Maria Berkman · Director
  • Mary Byron · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Adam Berman, Ceo. Newest notice filed Nov 5, 2020 (1 amendment). Read the notice at the SEC.

equitySEC
Dec 2017$1 MNo. 1Under $2 million

Alleviant Medical, Inc.: Raise no. 1, Dec 2017

Investors in this round

15 investors had bought by the notice of Mar 30, 2018: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $2 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Albertien Alex Greijdanus · Executive Officer, Director
  • Avni Alex Patel · Executive Officer, Director
  • Christopher Alex Arevalos · Executive Officer, Director
  • Jacob Kriegel · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jacob Kriegel, Chief Executive Officer. Newest notice filed Mar 30, 2018. Read the notice at the SEC.

debt, optionsSEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Alleviant Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2025).

    SEC Form D · Jan 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Alleviant Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Alleviant Medical, Inc.
NameRoleNamed in
Adam BermanExecutive officerJan 2025
Albertien Alex GreijdanusExecutive officerMar 2018
Avni Alex PatelExecutive officerMar 2018
Christopher Alex ArevalosExecutive officerMar 2018
Jacob KriegelExecutive officerMar 2018
Adam BermanDirectorJan 2025
Brian R SmithDirectorJan 2025
Christopher R KasterDirectorJan 2025
Geoff R PardoDirectorJan 2025
Ian R MeredithDirectorJan 2025
Jay R SchmelterDirectorJan 2025
Kirk R NielsenDirectorJan 2025
Maria R BerkmanDirectorJan 2025
Gowda R AshokDirectorFeb 2023
Kirk R NielsonDirectorFeb 2023
Maria BerkmanDirectorFeb 2023
Ashok GowdaDirectorNov 2020
Christopher KasterDirectorNov 2020
Jacob KriegelDirectorNov 2020
Kirk NielsenDirectorNov 2020
Mary ByronDirectorNov 2020
Albertien Alex GreijdanusDirectorMar 2018
Avni Alex PatelDirectorMar 2018
Christopher Alex ArevalosDirectorMar 2018